Sign in
Taking peopleNo phase

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

Key facts

Who runs it
Centre for Addiction and Mental Health
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
10 Nov 2022
Expected to end
Dec 2027
Type of study
Interventional, 2 groups
Treatments tested
  • CBT
Record updated
20 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patient has been referred to or intends to participate in either the AUD or CUD Integrated Care Pathway (and is therefore willing to participate in group psychotherapy)
  • Able to communicate and provide informed consent in English
  • 18 years of age or older
  • Willing and able to safely abstain from substances (other than nicotine or tobacco products), including alcohol and cannabis, for 12 hours prior to the eligibility and task-based assessments
  • Meets DSM-5 diagnostic criteria for AUD (AUD group) or CUD (CUD group)
  • Meets criteria for risky drinking, defined as > 10 drinks per week for females and > 15 drinks per week for males on average over the past 30 days (AUD group) or daily or near-daily cannabis use over the past 30 days, defined as ≥ 4 days of cannabis use per week on average (CUD group)

Who cannot take part

  • Unstable psychiatric or medical status (e.g., acute psychosis or mania) or unstable use of another substance that may interfere with participation in groups (e.g. active fentanyl use)
  • Active suicidal ideation at time of assessment
  • Suicide attempt within the past month
  • Enrollment in another study that conflicts with the procedures or scientific integrity of this study
  • Individuals planning to be out of the province for a substantial amount of time during the treatment period will not be permitted to enroll

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This 2-arm study will recruit participants with 1) alcohol use disorder and 2) cannabis use disorder for a 12-week cognitive behavioral therapy, following a thorough baseline assessments on executive function, incentive salience, and negative emotionality.

The 2 groups in the trial

  • Alcohol Use DisorderOther group

    Participants will be treated with 12 weeks of CBT for AUD (group therapy) and have the option to receive evidence-based pharmacotherapy for AUD guided by a pharmacotherapy algorithm.

    Treatment: CBT

  • Cannabis Use DisorderOther group

    Participants will be treated with 12 weeks of CBT + motivational enhancement therapy for CUD (group therapy).

    Treatment: CBT

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
20 March 2026